Alkem Laboratories Board Approves Financial Results, Recommends Dividend, and Re-appoints Director
Alkem Laboratories Limited held its Board of Directors meeting on May 28, 2026. During the meeting, the Board approved the audited financial results for the quarter and the financial year ended March 31, 2026, and recommended a final dividend for the shareholders’ consideration.The Board confirmed that the Auditors expressed an unmodified opinion on the Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026.
In a key corporate governance decision, the Board approved the re-appointment of Mrs. Madhurima Singh as an Executive Director of the Company. This appointment is for a term of five consecutive years, effective from December 20, 2026, up to December 19, 2031.
Financial and Governance Outcomes
The Board also provided definitive timelines and recommendations related to the company's financial performance and dividend distribution:Financial Year Highlights:
The Board recommended a final dividend of Rs. 10 (Rupees Ten only) per equity share, where the face value of the equity share is Rs. 2/- each, for the financial year ended March 31, 2026.
Annual General Meeting (AGM) Schedule:
The 52nd Annual General Meeting (AGM) of the Company has been scheduled for August 27, 2026. Key dates associated with the AGM and dividend payment include:
| Event | Date | Details |
|---|---|---|
| AGM Date | August 27, 2026 | Date for the 52nd AGM of the Company |
| Cut-off Date | August 20, 2026 | Date fixed for the purpose of the AGM |
| Record Date | August 07, 2026 | Record date for the purpose of dividend payment |
| Dividend Payment | On or from September 01, 2026 | Proposed payment date, subject to shareholder approval |
The recommendation for the final dividend is subject to the approval of the shareholders at the ensuing Annual General Meeting.
ALKEM Stock Price Movement
On Wednesday, Alkem Laboratories Limited shares edged higher to close at ₹5451.5, gaining 1.77% for the day. The equity saw strong market participation, trading on a volume of 186,374 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.